Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus usual-use celecoxib in chronic hip or knee osteoarthritis
2005-004270-25Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in knee osteoarthritis (OA) and hip osteoarthritis (2 arms), sponsored by Pfizer. Primary endpoint: Number of osteoarthritis flares. Started Oct 2005; status: completed.
02
Drugs
celecoxib
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on 2005-004270-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004270-25.